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Summary 
Work Package 2 of the ANCIEN project assessed the actual and future numbers of elderly care-
dependent people in four selected countries: Spain, Poland, Germany and the Netherlands. Such 
projections are needed to support provisions for future LTC needs. These countries were 
representative of European epidemiology and of different systems for the provision of long-term care.  
We used the mortality forecasts of the EUROPOP 2008 scenarios as a basis for projections of the 
number of disabled elderly people, according to several assumptions about how disability and 
mortality are related. We added scenarios on the effects of smoking and BMI. The data were delivered 
by Eurostat (forecasts of mortality and populations), the ANCIEN Work Package 1 (elderly people in 
institutes), SHARE (elderly people living in the community) and the Rotterdam study (prospective 
study on ageing).  
The main determinant of future numbers of disabled elderly people turned out to be the demographic 
ageing of the large baby boom cohorts. This would cause increases of 44% (Germany), 65% (Spain), 
82% (the Netherlands) and 57% (Poland). The impact of life extension depends on the correlation of 
old age disability and mortality, and is moderate under reasonably conservative assumptions: (+11% 
for Germany, +7% for Spain, +9% for the Netherlands and +22% for Poland). For Poland, 
convergence to a German age schedule of disability would limit this increase. Obesity and (quitting) 
smoking have very little effect.  
We conclude that the future numbers of long-term care patients can be robustly predicted and will be 
mainly determined by demographic ageing.  
Foreword 
The report is constructed as a summary of all the findings, with added appendices describing 
procedures in more detail or giving further explanations. We summarised the results in as few tables 
and figures as possible. User-friendly spreadsheets –summarising all the output will be made available 
for the public at the ANCIEN website (http://www.ancien-longtermcare.eu/).  
The LIPRO macrosimulation multi-state projection model is already available on the NIDI website 
(http://www.nidi.knaw.nl/; for a description see http://nidi.nl/Content/NIDI/output/lipro/nidicbgs-publ-
23.pdf). The LIPRO model is (relatively) user friendly, and can read input from spreadsheets. All 
spreadsheet input will be uploaded as a deliverable. They contain the input in (not too difficult) 
mathematical format. A dedicated manual on how to manipulate the input sheets together with the 
LIPRO model to generate the output, and how to read the output, will be made available on the 
ANCIEN website. The method to generate consistent incidence from prevalence is added in an 
appendix. On the same website, the R syntax will be made available. With the input sheets and some 
patience, all scenarios using the same principles can be easily run. 
                                                      
* Nederlands Interdisciplinair Demografisch Instituut (NIDI), Postbus 11650, 2502 AR Den Haag, Phone: +31 
70-3565248, GSM: +32 4 94 98 92 99. Comments or questions can be addressed to Nicole van der Gaag, 
gaag@nidi.nl. The authors gratefully acknowledge the positive comments and support of the other members of 
the ANCIEN project (http://www.ancien-longtermcare.eu/), particularly Peter Willemé and Esther Mot. Joop de 
Beer, Senior Researcher at NIDI, initially advised on how to set up the more simplified forecasting models. 2 | BONNEUX, VAN DER GAAG & BIJWAART 
 
Introduction 
In 2011, the large post-war baby boom that started in 1946 began to reach the retirement age of 65. A 
‘baby crash’ (a sharp decline in fertility) followed the baby boom, and is causing serious imbalances 
between the baby-boom generations and the small baby-crash generations born after the 1970s.
1 To 
address policy questions related to the provision of health care services in an ageing population, 
increasing emphasis has been put on the future development of long-term care need, supply and use, 
and the functioning of LTC systems. In this paper we use demographic models to project future needs 
of long-term care in four countries of the EU, Germany (DE), Spain (ES), the Netherlands (NL) and 
Poland (PL), based on the EUROPOP 2008 mortality forecasts.
2 These four countries have been 
chosen based on systems analysis of elderly care in the EU (see ANCIEN WP 1). However, the simple 
generic methods are applicable to all countries that can deliver mortality and prevalence data of basic 
activities of daily living (ADL) and selected risk factors. (For a further exploration of the rationale, see 
Appendix A1). 
We take the mortality predictions of the EUROPOP 2008 forecasts for granted. We explore the 
prevalence of disability by two simple sets of scenarios. The first set explores the effect of different 
relationships between the incidence of senescent disability and mortality. The second set explores the 
effects of risk factors, notably obesity and smoking. We generate population figures of disabled and 
non-disabled elderly people (65+) till 2060. For reasons of parsimony and relevance, we only present 
results up to 2040. 
1. Methods 
Long-term care need is operationalised as having “at least one limitation in basic activities of daily 
living (basic ADL-disability)”, based on the Katz ADL disability scale (Katz et al., 1963). Basic ADL-
disability is defined as self-reported difficulty with any of the following items: a) bathing, b) dressing, 
c) eating, d) indoor transferring and e) toileting and continence. As basic ADL items behave in a 
hierarchical way (disabilities are added by senescence), a mean score on these items is a good 
indication of severity. 
Data used 
For a summary of all data and their sources, see Table A1. We describe the population in terms of 
state (disabled or not) and risk factor status (smoking or not, obese or not). We define country-specific 
populations by age, sex, state and risk factor status-specific prevalence in 2008, derived sex and state 
specific basic ADL incidence and risk and state-specific basic ADL mortality. 
The main source of country-specific information is SHARE, the Survey of Health, Ageing and 
Retirement in Europe (http://www.share-project.org/; see Appendix A2 for more information). This 
large European dataset contains all necessary information on elderly people residing in the community 
(a specific country set contains relatively low numbers). We extracted the prevalence of basic ADL 
disability by single year of age. We added the numbers of residents in long-term care facilities, derived 
from WP1. Risk factors were distributed over the LTC population as in SHARE. In the Netherlands, 
many elderly people live in institutions, and not all are disabled. We adjusted this by available data on 
elderly people from the long-term care register. For other countries, we assumed that all elderly people 
living in residences were disabled. For Poland no LTC data were available (but disability is so high 
that adding residents would not make a major difference). The results are shown in Table A2. To make 
projections over changing age distributions, age-specific disability figures need to be smoothed (to 
avoid accentuation of peaks and falls by extrapolations). We did this by using Gompertz models.  
                                                      
1See: http://europa.eu/legislation_summaries/employment_and_social_policy/situation_in_europe/c10160en.htm 
2See: http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-SF-10-001/EN/KS-SF-10-001-EN.PDF DEMOGRAPHIC EPIDEMIOLOGIC PROJECTIONS OF LTC NEEDS IN SELECTED EUROPEAN COUNTRIES | 3 
 
To understand the effects of a dynamic change of stocks (prevalence) in populations, we need to 
model flows (incidence) (Barendregt, Bonneux and Van der Maas, 1994). We modelled the flow into 
disability by reconstructing a hypothetical incidence from prevalence and state and risk factor specific 
mortality (see A3 for details on methods). This flow is irreversible (does not take into account 
recovery), and it therefore summarises all changes ‘in and out’ of disability in a single transition of 
non-disabled to disabled (the net inflow). Senescent disability is a chronically progressive but highly 
fluctuating process.  Persons generally enter the state of irreversible disability after a long period of 
ups and downs, which would lead to many events of ‘incidence’ and subsequent ‘recovery’. 
Identification of incidence and recovery of disability is always tenuous in epidemiologic surveys. The 
disability process is slow and fluctuating, the beginning is characterised by series of incidence, 
recovery and misclassification at the margins between disabled and non-disabled people.  
State, sex and age-specific mortality is identified by using prospective data from the Rotterdam Study 
Project (see Appendix A1 for data on methods and results). Proportional hazard ratios were estimated 
for mortality risk ratios following disability and risk (obesity or smoking) using Cox regression. 
Interaction with age was statistically not significant and ignored. Population mortality, state 
prevalence and risk ratios identified sex, state and age specific mortality. 
Making forecasts 
At this stage, we have a population incidence of disability by risk factor status and mortality by 
disability state and risk factor status that consistently reproduces the observed population prevalence 
and mortality for 2008. These can be applied to projections of populations, flowing in at age 55, and to 
projections of mortality as made by the EUROPOP mortality forecasts. For background information 
on the EUROPOP scenario and the macrosimulation model used, see Appendix A4. 
It is important to note that mortality forecasts such as those of Eurostat, using simple mathematical 
models, contain sheer endless numbers of implicit ‘business as usual’ assumptions. The ANCIEN 
forecast model makes a few of these assumptions explicit. We take from the mortality forecasts the 
relative mortality declines and keep these consistent over state and risk factor status, but full 
consistency is not desirable, as mortality may be an important outcome of scenario forecasts. In 
smoking, consistency would be impossible, as the EUROPOP 2008 scenario does not take into 
account the different stages of the smoking epidemic that women and men are in. In the male baby 
boom cohorts, the smoking epidemic is receding, while in the female baby boom cohorts smoking hits 
it peak. Future life expectancy of women compared to men as forecast by EUROPOP 2008 is therefore 
necessarily overestimated, based on explicit knowledge of the smoking epidemic. 
The demographic simulation model focuses on ages 65 and older, but starts at age 55 as ‘run in’ 
population. We identified the numbers that reach their 55th birthday in each calendar year by using the 
EUROPOP Population forecasts (see A4 for more information on the main assumptions governing the 
EUROPOP 2008 forecasts). We implicitly introduce the mortality and migration assumptions at ages 
younger than 55 of the EUROPOP 2008 scenarios. As our scenarios cover the period 2008-2060, our 
projections are based on the population already living. The model does not therefore need to include 
fertility. Moreover, since both immigration and emigration rates tend to be low for elderly people, 
migration is excluded from the model as well. The EUROPOP 2008 scenarios do not make explicit 
assumptions on the future determinants of the mortality decline. WP2 of ANCIEN does, by dividing 
the population into able and disabled and considering the effects of obesity and smoking as risk 
factors. As a consequence, the results of our projections of the population aged 65+ could be slightly 
different from the EUROPOP 2008 results. 
Many mortality forecasts are possible. In the past, simple linear mathematical models projecting age-
specific mortality outperformed more complex methodologies. For consistency and comparability, we 
use the EUROPOP 2008 mortality forecasts, built on such similar linear methods. These project an 
optimistic future of mortality decrease, based on the unprecedented mortality decrease in the elderly 
(65+) after the Second World War. All scenarios therefore modify assumptions about the relation 
between disability incidence and mortality. 4 | BONNEUX, VAN DER GAAG & BIJWAART 
 
2. Scenario  assumptions 
Scenarios without risk factors 
Constant incidence and mortality scenario 
To be able to assess the potential of demographic change, independent from changes in mortality, we 
postulated a (pessimistic) scenario with no mortality change: CONST, from constant mortality (see 
Table A1 for a short summary of all scenarios). Change in both incidence and mortality is 0%. 
CONST therefore reflects the demographic change introduced by the cohorts that entered at age 55, 
and reached 65 in the years 2008-2060 (or more or less the birth cohorts 1943-1995). These 
predominantly reflect the ageing of the baby boom cohorts, for simplicity (size and duration of the 
baby boom varied considerably, even in the countries considered) defined as born between 1946 and 
1965. In the model, they will die between 2046 and 2065 (beyond the time horizon of 2060). In this 
report, we only present the results up to 2040; most relevant for policy-making. In the spreadsheets 
downloadable from the ANCIEN website, results run until 2060. All subsequent scenarios add 
decreasing mortality to this scenario. 
Constant prevalence scenario 
The prevalence scenario (PREV) applies constant age-specific prevalence ratios of disability to the 
changing populations.  This is a much used and simple technique to assess future care needs. The 
technique makes implicit assumptions that are made explicit by multi-state simulation. 
Chronological ageing scenario 
The chronology scenario (CHRON) assumes that age-specific incidence rates are dependent on age, 
which is the period since birth. Incidence is kept constant. The difference with the PREV scenario is 
caused by explicit assumptions about survival in disabled or non-disabled states. Indeed, in the 
prevailing scenario of decreasing mortality, prevalence will increase as decreasing mortality among 
the disabled extends their survival. 
Biological ageing scenario 
The biological scenario (BIOL) assumes that age-related disability is determined by biological (or 
prospective) age: the remaining years of life before death. This assumes a biologically plausible 
similar decline of disability incidence to that of mortality. The EUROP 2008 mortality forecasts 
assume a close interaction of the mortality decrease with age: mortality declines sharply at younger 
ages, but less at older age and close to nothing in the oldest ages. This is reflected in the biological 
forecasts. In general, biological scenarios predict the expansion of healthy life, but no expansion of 
disabled life. Up to now, this is most consistent with observations of severe disability in the available 
literature.  
Delayed ageing scenario 
The delayed ageing scenario is a conservatively modified ageing scenario. DELAY assumes that the 
disability is delayed in the life course to older ages, similar to mortality. While the biological scenario 
assumes close interaction of mortality decrease with age, the delay scenario postpones disability, 
similar to mortality, avoiding this interaction. Incidence is then declining less at younger ages 
(avoiding the very large disability declines of the multiplicative biological scenario), but declines more 
at older ages (more consistent with a hypothesis of postponed disability). As incidence decline at 
younger ages prevents more disability at older ages, the DELAY scenario is a biological scenario, but 
which is more conservative than the biological scenario BIOL.  DEMOGRAPHIC EPIDEMIOLOGIC PROJECTIONS OF LTC NEEDS IN SELECTED EUROPEAN COUNTRIES | 5 
 
Scenarios with risk factors: obesity 
The BMI scenario 
The background mortality and disability forecast is the EUROPOP 2008 mortality scenario with the 
DELAY disability scenario.  
The mortality of obese people does not differ much from the non-obese, but the prevalence of 
disability is (a lot) higher. Obesity increases the load on the weight-bearing joints of knees, hips and 
back, which causes changes in posture and accelerated wear and tear in the fragile joints of the human. 
This leads to loss of mobility, which with changes in cognition and balance is a major cause of 
disability. The BMI scenario projects the (increased) prevalence of obesity of inflowing future cohorts 
to the future but keeps these prevalences constant.  
The ‘back to leaner populations’ scenario 
This back-to-leaner populations (LEAN) is an optimistic scenario. It halves the prevalence of obesity 
in all inflowing 55 year old in the future.  This part of the assumption is not so extreme: the prevalence 
of obesity doubled more or less since the 1960s, so this scenario assumes a return to the prevalence of 
obesity of the 1960s. The extreme part is that this halving of obesity prevalence happened immediately 
in 2008... We adopted extreme scenarios, as risk factors had surprisingly little effect on numbers of 
disabled persons. 
FAT  
FAT is another extreme scenario, but pessimistic. It assumes that the prevalence of obesity is 
doubling. Again, this part of the assumption is not extreme: prevalence of obesity in the US is more or 
less double that of the modelled European countries. What is extreme is the suddenness of that 
increase. 
Scenarios with risk factors: smoking 
The background mortality and disability forecast is the EUROPOP 2008 mortality scenario with the 
DELAY disability scenario. However, as smoking is such a significant cause of death, the EUROPOP 
scenario makes strong implicit assumptions on smoking scenarios. As these are implicit and not 
necessarily consistent (trends are very different in women and men), we did not try to model them 
explicitly. Explicit assumptions on smoking will cause unavoidable changes in the mortality forecasts.  
Disability incidence of smokers is close to the incidence of non-smokers. Basic ADL disability in 
smokers is mainly caused by chronic obstructive pulmonary disease, but this occurs only in a fraction 
of smokers, and only with severe disease. This causes the typical health paradox of smoking. High 
mortality inhibits life extension and compresses age-related disability.  
The smoking scenario 
The smoking scenario (SMOK) projects the (still high) prevalence of smoking (SMOK) of younger 
cohorts to the future, and assumes they will go on smoking. That is a ‘worst case’ pessimistic 
assumption. It is not very realistic, as disabled smokers will often quit smoking as a consequence of 
the disease that disabled them. 
The trend scenario 
The trend scenario (TREND) is a realistic future scenario. It adds the assumption that future cohorts 
and smokers will successfully quit at a rate of 2% per year (which is close to recent observations).  
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The no smoking scenario  
The no-smoking scenario (NoSMOK) modifies the SMOK scenario, by assuming that in the future no 
55 year old will be smoking anymore, but that the remaining smokers will go on smoking. These large 
smoking cohorts will then only be extinct, as it were, by around 2055. This shows the inertia of 
demographic change: people start smoking as a teenager, but will die of smoking on average fifty 
years later. In 2040, many smokers will still survive at the age of highest disability, which can cause 
paradoxical results.  
The no-smoking and accelerated quitting scenario 
This scenario (NoSQuit) adds high quit rates to the stop-smoking (NoSMOK) scenario. This is an 
extreme ‘no smoking’ scenario, as smokers both die or quit and are not replaced by new cohorts of 
smokers. It also shows the potential of increasing disability, but also decreasing smoking related 
mortality, compared to the trend scenario. 
 
3. Results 
Life expectancy results 
The life tables show healthy life expectancies, which combine prevalence and mortality in a life table. 
Multi-state life tables modelling incidences and mortality are mathematically more consistent, but they 
are not easy to understand (they define synthetic cohorts) and are less applicable to population figures. 
Healthy life tables are mathematically not consistent (they combine stocks, a result from historical 
flows, with actual flows: mortality), but they are easy to make and to understand. They split up the 
remaining life expectancy at age 65, calculated by applying mortality rates to a synthetic cohort, in a 
fraction with or without disability based on age specific prevalences. Table 1 shows that the ANCIEN 
method of parsing mortality over disability state and risk factor status succeeds well in reproducing the 
EUROPOP life expectancies, while adding information on the duration of disability in the synthetic 
cohort.  
The tables can be read as follows: for Germany, life expectancy is at age 65 20.1 years for women and 
16.8 years for men. Of these, German men would live 3.3 years with basic ADL disability and German 
women 4.8 years (reflecting the higher disability prevalence among women). German smokers live on 
average 3.8 years less (note that this difference is modelled by using Dutch relative mortality risks) – 
2.4 ‘good’ years free of basic ADL disability and 1.4 ‘bad’ year. Obese persons live 0.4 years less 
(which would only be statistically significant in very large studies), but they lose 1.5 years free of 
basic ADL disability, with a remarkable and often noted difference between women and men. Women 
pay the price of a long life, less muscle mass (to cater for larger fat reserves, to be used during 
pregnancy and breast feeding) and skeletal remodelling caused by the conflicting demands of a bipedal 
life and child birth. 
While the Dutch have a lower life expectancy than the Germans and the Spaniards, they have a higher 
disability-free life expectancy. The Polish population shares the fate of all former EU socialist 
regimes/political systems: high mortality, particularly among men, combined with high disability. 
Smoking, alcohol and poor diets are to be blamed. The good news for the Polish population is that 
they belong to the forerunners, and that we may sincerely hope that our disability forecasts still reflect 
a bleaker past and are therefore too pessimistic. However, if demography teaches us one thing, it is 
that history will never be ignored: it takes many decades to leave the past behind. 
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Table 1. Non-disabled life expectancies at age 65 by risk factor status in 2008 
2008 Women  Men 
  Ex nDex  Dex  Ex nDex  Dex 
D E         
Europop  20.07     16.82    
ANCIEN 20.10 15.35  4.75 16.87 13.56  3.32
nS  20.33 15.49  4.84 17.33 13.87  3.46
S  16.47 13.13  3.34 13.66 11.49  2.16
nO  20.22 15.88  4.34 16.92 13.59  3.33
O  19.73 13.39  6.33 16.56 13.09  3.47
E S         
Europop  20.93     17.09    
ANCIEN 20.96 14.87  6.09 17.14 13.79  3.35
nS  21.04 14.90  6.14 17.81 14.24  3.57
S  17.28 12.98  4.30 14.14 11.79  2.35
nO  21.11 15.69  5.42 17.19 13.83  3.36
O  20.73 13.15  7.58 16.80 13.23  3.57
N L         
Europop  19.90     16.55    
ANCIEN 19.94 15.64  4.30 16.59 14.39  2.20
nS  20.44 15.95  4.49 17.32 14.93  2.38
S  16.60 13.63  2.97 13.80 12.30  1.50
nO  20.03 16.00  4.03 16.65 14.44  2.21
O  19.56 13.89  5.68 16.13 13.65  2.48
P L         
Europop  18.53     14.45    
ANCIEN  18.56  10.85 7.71 14.50 9.91 4.59
nS  18.80 10.97  7.83 15.42 10.49  4.94
S  14.83 9.11 5.72 11.54 8.09 3.45
nO  18.59 11.02  7.58 14.57 10.09  4.48
O  18.63  10.76 7.86 14.27 9.17 5.10
(ex, life expectancy nDex life expectancy free of disability, Dex, life expectancy with disability DE (Germany), ES 
(Spain), NL (Netherlands), PL (Poland); nS (non-Smokers), S (Smokers), nO (not obese, BMI < 30), O (BMI > 30). 
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Figure 1. Life expectancy at age 65 by disability status; by country (a and b) and by risk factor status 
(DE, c and d) 
 
 
4.  Modelled life expectancies in 2040 
By disability status 
EUROPOP 2008 assumes European convergence: those countries with the lowest life expectancy in 
2008 make the largest gains and vice versa. When introducing dynamic states, the forecasted life 
expectancy will differ from the EUROPOP scenarios. The constant incidence scenario (CHRON) 
separates mortality into two rates: a mortality rate from the disabled and the non-disabled. This adds 
the increased life expectancy of disabled people to the prevalence scenario. The Biology scenario adds 
little disability, compared to 2008, as it is assuming parallel incidence and mortality decline. By 
parsing mortality in two states, the relative decline of high mortality in the disabled state adds to the 
forecasted life expectancy. The delay scenario, assuming a linear and more age-independent incidence 
decline, adds disability by assuming less incidence decline among the younger. The younger disabled 
will live longer than the older by virtue of being younger. The scenario is therefore more conservative 
than the biological scenario. Noteworthy is the atypical result of the delay scenario in Poland 
compared to the three other EU countries: this is caused by high disability among younger persons, 
less age dependency and therefore less delay effect.  DEMOGRAPHIC EPIDEMIOLOGIC PROJECTIONS OF LTC NEEDS IN SELECTED EUROPEAN COUNTRIES | 9 
 
Table 3 and Figure 2 show the consequences of these changes in incidence and mortality, applied to 
the populations of the four countries studied. Table 3 shows the differences between the main 
scenarios in terms of numbers and percentages of persons with basic ADL disability as well as annual 
change in mortality and incidence for the period 2008-2040. Figure 2 shows the change in the number 
of basic ADL disabled persons in 2040 compared to 2008 distinguished by the different components, 
as specified by the assumptions. “Demography” shows the consequences of the flowing in of the baby 
boom cohorts. “Life ext” shows the consequences of life extension, according to the moderate ‘Delay’ 
scenario. “Chron” shows the consequences of a constant disability incidence (an extreme case).  
Germany shows the most moderate changes. This is a consequence of lower birth rates after the 
second world war. Spain shows a somewhat smaller effect of life extension: a consequence of a lower 
mortality in 2008 and therefore, in the Europop convergence scenario, somewhat lower life 
expectancy increase. The Netherlands is demographically the most unstable, with a large baby boom 
cohort moving in. This is exacerbated by the strong age dependency of the prevalence of basic ADL 
disability in the Dutch data.  
Table 2. Changes in healthy life expectancies at age 65 in 2040 
2040 F  M 
Ex  nDex Dex  ex  nDex Dex 
DE 
Const    20.10 15.35  4.75 16.87 13.56  3.32 
Europop 2040  23.23  20.13 
Prev  23.23 17.16  6.07 20.13 15.56  4.58 
Chron  23.22 16.96  6.26 20.11 15.30  4.81 
Biol  23.47 18.69  4.77 20.48 16.73  3.75 
Delay  23.34 17.78  5.56 20.37 16.25  4.12 
ES 
Const  20.96 14.87  6.09 17.14 13.79  3.35 
Europop 2040  23.76  20.29 
Prev  23.76 16.19  7.57 20.29 15.82  4.47 
Chron  23.76 16.02  7.74 20.26 15.54  4.71 
Biol  24.01 17.89  6.12 20.61 16.94  3.67 
Delay  23.89 17.02  6.87 20.48 16.37  4.11 
NL 
Const  19.94 15.64  4.30 16.59 14.39  2.20 
Europop 2040  23.11  19.80 
Prev  23.11 17.45  5.66 19.80 16.70  3.10 
Chron  23.11 17.27  5.84 19.77 16.47  3.31 
Biol  23.36 18.98  4.38 20.07 17.59  2.48 
Delay  23.25 18.26  4.99 19.99 17.26  2.73 
PL 
Const  18.56  10.85 7.71  14.50 9.91 4.59 
Europop 2040  22.25  18.58 
Prev  22.25 12.21 10.04 18.58 11.95  6.63 
Chron  22.24 11.96 10.28 18.51 11.48  7.03 
Biol  22.52 13.95  8.57 18.93 13.06  5.86 
Delay  22.37 12.89  9.48 18.77 12.45  6.31 
ex, life expectancy nDex life expectancy free of disability, Dex, life expectancy with disability (all expressed in 
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Table 3. Changes in incidence and mortality (age standardised) and consequences for the populations 
in 2040 
annual change  65+ (X 1000)  Index 
mortality incidence  N  n  disabl  Prev 65+  ADL 
DE 
2008 16519  3222  19.5%  100  100
CONST 0%  0%  21098  4636  22.0%  128  144
PREV -1.35% NA  24212  5724  23.6% 147  178
CHRON -1.35%  0%  24163 5933  24.6%  146  184
BIOL -1.35%  -1.35%  24404  4475  18.3%  148  139
DELAY -1.35%  -0.91%  24307  5147  21.2%  147  160
ES 
2008 7520  1794  23.8%  100  100
CONST 0%  0%  12875  2952  22.9%  171  165
PREV -1.34% NA  14375  3509  24.4% 191  196
CHRON -1.34%  0.00%  14351 3613  25.2%  191  201
BIOL -1.34%  -1.35%  14469  2770  19.1%  192  154
DELAY -1.34%  -0.87%  14419  3161  21.9%  192  176
NL 
2008 2415  403  16.7%  100  100
CONST 0%  0%  4090  734  17.9%  169  182
PREV -1.41% NA  4699  923  19.7% 195  229
CHRON -1.41%  0.00%  4689  961  20.5%  194  239
BIOL -1.41%  -1.39%  4734  709  15.0%  196  176
DELAY -1.41%  -0.95%  4718  803  17.0%  195  199
PL 
2008 5131  1852  36.1%  100  100
CONST 0%  0%  7501  2914  38.8%  146  157
PREV -1.53% NA  9120  3745  41.1% 178  202
CHRON -1.53%  0.00%  9155 3907  42.7%  178  211
BIOL -1.53%  -1.61%  9275  3218  34.7%  181  174
DELAY -1.53%  -0.91%  8996 3548  39.4%  175  192
Note: N is the population (N), N disabl are the numbers disabled. The index compares the relative change to 
2008 (= 100). Prevalence is the period prevalence of basic ADL disabled in the population 65+ in the year 
2040. The annual yearly incidence is the average age adjusted change over a year in the period 2008-2040. 
See table with data and assumptions for scenarios. 
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Figure 2. Change in basic ADL disabled elderly in 2040, compared to 2008 
  
Note: “Demo” is the expected change, with constant mortality and incidence. Life extension adds the numbers of 
the middle ‘Delay’ scenario. “Chron” adds the numbers if incidence of disability would remain constant. 
A special case: Poland 
Poland is a former socialist country, whereas Germany was split into two parts: the German 
Democratic Republic (GDR or East Germany), which became a member of the communist bloc, and 
the Federal Republic of Germany (FRG or West Germany), which became a free market economy. 
Figure 3 shows the evolution of life expectancy at age 65 for men and women, Poland and both parts 
of Germany and the relative mortality differences between the three regions (source: human mortality 
database, www.mortality.org).  
Figure 3 A and B. Evolution of life expectancy at age 65 from 1958 till 2009, Poland (PL), Eastern 
Germany (EDE) and Western Germany (WDE) 
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Differences between the former socialist regions and western free market economies are 
predominantly caused by suicide, alcoholism and a longer smoking epidemic (Bonneux, Huisman & 
de Beer, 2010). While smoking kills, despair, depression and alcoholism are important causes of 
disability. As the mortality signs of a bleak society are ubiquitous in the former socialist countries of 
Eastern Europe, they may explain high levels of disability, particularly in those who lived their adult 
life (15-55) under communist regimes (Bonneux, Huisman & de Beer, 2010). However, the mortality 
figures also show rapid convergence of life expectancy in Eastern Germany, pulled forward by the 
unification of Germany. Convergence within Europe may have the same effects. 
Therefore, to take into account the different disability history of Poland, we specified an additional 
‘Convergence’ scenario. We compared the German and Polish incidence of disability in both delay 
scenarios, and then we assumed a gradual linear convergence of disability incidence to the German 
disability incidence over one generation: under this scenario the Polish would reach the German 
disability prevalence in 2040. From then onward, the Polish disability incidence follows the German 
delay scenario. For transparency, we compared the Polish and the German figures only. 
Table 4. Changes in incidence and mortality and consequences for the year 2040 
annual change  65+ (X 1000)  Index 
mortality incidence  N  n  disabl  Prev  65+  ADL 
DE 
2008 16519  3222  19.5%  100  100
CONST 0%  0% 21098  4636  22.0%  128  144
PREV -1.35%  NA 24212  5724  23.6%  147  178
CHRON -1.35%  0% 24163  5933  24.6%  146  184
BIOL -1.35%  -1.35% 24404  4475  18.3%  148  139
DELAY -1.35%  -0.91% 24307  5147  21.2%  147  160
PL 
2008 5131  1852  36.1%  100  100
CONST 0%  0% 7501  2914  38.8%  146  157
PREV -1.53%  NA 9120  3745  41.1%  178  202
CHRON -1.53%  0.00% 9155  3907  42.7%  178  211
BIOL -1.53%  -1.61% 9275  3218  34.7%  181  174
DELAY -1.53%  -0.91% 8996  3548  39.4%  175  192
CONVERGENCE -1.53% -1.72% 9306  3058 32.9%  181  165
 
The EUROPOP 2008 convergence scenario also causes more significant mortality declines in Poland 
than in Germany (although less than was observed in Eastern Germany: see previous figure). The 
convergent scenario of disability incidence in Poland would have quite important consequences: it 
would reduce the numbers of disabled elderly people more than in the biological scenario. However, 
even then, Poland would still face important increases of disabled elderly; a consequence of 
demography and demographic inertia. The survivors of the communist era and its legacy of high 
disability will persist for many years to come. 
5.  Disability changes by risk factor status in 2040 
Table 5 shows the consequences of changes in risk factors in 2040 in the life table (delay scenario at 
baseline). The scenarios are satisfactorily consistent. The sharp mortality decrease, equal between 
smokers and non-smokers, decreases the life expectancy gap between both, but only slightly. DEMOGRAPHIC EPIDEMIOLOGIC PROJECTIONS OF LTC NEEDS IN SELECTED EUROPEAN COUNTRIES | 13 
 
Differences in life expectancy between the obese and the non-obese are minor, but cause relatively 
marked changes in life expectancy with disability. 
Table 5. Life expectancy at age 65, by risk factor status in 2040 
2040 F  M 
Ex nDex Dex  ex  nDex Dex 
DE 
2008 20.10  15.35  4.75  16.87  13.56  3.32 
2040 (delay)  23.34  17.78  5.56  20.37  16.25  4.12 
nS 23.58  17.91  5.67  20.75  16.54  4.21 
S 19.80  15.75  4.05  17.01  14.15  2.86 
nO 23.52  18.43  5.10  20.54  16.74  3.81 
O 23.05  15.64  7.41  19.80  14.28  5.52 
ES 
2008 20.96  14.87  6.09  17.14  13.79  3.35 
2040 (delay)  23.89  17.02  6.87  20.48  16.37  4.11 
nS 24.01  17.05  6.96  21.08  16.79  4.29 
S 20.32  15.26  5.06  17.38  14.34  3.04 
nO 24.12  18.06  6.06  20.66  16.88  3.78 
O 23.74  15.25  8.49  19.93  14.44  5.49 
NL 
2008 19.94  15.64  4.30  16.59  14.39  2.20 
2040 (delay)  23.25  18.26  4.99  19.99  17.26  2.73 
nS 23.70  18.52  5.17  20.64  17.77  2.88 
S 19.98  16.41  3.56  17.07  15.13  1.95 
nO 23.41  18.74  4.67  20.12  17.59  2.53 
O 22.97  16.49  6.48  19.37  15.54  3.83 
PL 
2008 18.56  10.85  7.71  14.50  9.91  4.59 
2040 (delay)  22.37  12.89  9.48  18.77  12.45  6.31 
nS 22.59  13.01  9.59  19.58  12.93  6.65 
S 18.69  11.51  7.17  15.67  10.90  4.77 
nO 22.57  13.87  8.70  18.94  13.05  5.89 
O 22.37  11.38  10.99  18.36  10.42  7.94 
ex, life expectancy nDex life expectancy free of disability, Dex, life expectancy with disability. NS and NO, 
non-smokers and non-Obese, S and O smokers and Obese. All in years. 
Table 6 and Figure 4 show the effects of quite extreme risk factor scenarios for obesity. The BMI as a 
usual scenario assumes a constant BMI in the future. The effects are therefore determined by the 
prevalence of BMI in the younger cohorts that are flowing in. As the reader may notice, the prevalence 
of an increased BMI (30+) in these cohorts was relatively low in Germany, higher in the Netherlands, 
high in Spain and very high in Poland. We therefore did not simulate more scenarios, as these four 
countries show a wide range of responses to an increased BMI. 14 | BONNEUX, VAN DER GAAG & BIJWAART 
 
The FAT scenario assumes that all future cohorts have a doubled prevalence of obesity (BMI 30+), 
which is quite extreme. The LEAN scenario assumes that all future cohorts have a halved prevalence 
of obesity. If changes were more gradual, effects would be smaller. But even these extreme scenarios, 
with relatively significant consequences for an individual life course, have a rather limited impact on 
the prevalence of disability. Every individual born before 1975 will contribute to the prevalence of 
disability among the 65+ in 2040, while only the obese fraction of that population can contribute to the 
excess prevalence of disability caused by obesity. The effect on the total population is limited, as 
expected from the rather limited changes in life expectancy.  
The Polish population forecasts are again an outlier, due to the combined effect of both a high 
prevalence of obesity and disability. The lower mortality among the disabled obese population (called 
the obesity paradox in epidemiology) can then be significant enough to increase the total population.  
Table 6. The effect of changing BMI on projected ADL disability in 2040 
65+ (X 1000)  Index 
2040 
Prevalence 
of obesity  N n  disabl  Prev  65+  ADL 
DE 
DELAY NA  24307  5147  21,2%  147  160
BMI 12,7% 24359  5017  20,6%  147  156
LEAN 7,2% 24389  4907  20,1%  148  152
FAT 23,7% 24298  5237  21,6%  147  163
ES  
DELAY NA  14419  3161  21,9%  192  176
BMI 25,3% 14430  3157  21,9%  192  176
LEAN 14,0% 14457  3021  20,9%  192  168
FAT 48,2% 14376  3430  23,9%  191  191
NL 
2040 
DELAY NA  4718  803  17,0%  195  199
BMI 20,3% 4713  817  17,3%  195  203
LEAN 11,2% 4723  789  16,7%  196  196
FAT 38,5% 4693  873  18,6%  194  217
PL 2040 
DELAY NA  8996  3492  38,8%  175  189
BMI 28,7% 9238  3575  38,7%  180  193
LEAN 16,1% 9257  3463  37,4%  180  187
FAT 54,1% 9199  3799  41,3%  179  205
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Figure 4. Change in basic ADL disabled elderly in 2040, compared to 2008, obesity scenarios 
 
Note: “Lean” shows the consequence when the prevalence of obesity in the future cohorts dramatically halves 
after 2008, “BMI” adds the numbers of disabled when the prevalence of obesity remains constant at the 
values of 2008 and “Fat” when the prevalence dramatically doubles. Even extreme scenarios have small 
effects. 
Smoking trends are implicitly taken into account by the Europop 2008 forecast methodology, and in 
the disability scenarios that do not take into account risk factor status. This methodology does not take 
heterogeneity into account. However, smoking trends were a major cause of the mortality decline 
among men in European democracies since the 1970s, but no cause of mortality decline among 
European women, born before the Second World War. By societal consensus, these female 
generations were not ‘allowed’ to smoke. This will change in the future. The female baby boom 
generation took up smoking in large(r) numbers, and will pay the price with increased mortality. In 
general, this means that the female future mortality decline has been overestimated in the Europop 
mortality scenario, while the male future mortality decline has been underestimated.  
Table 7 and Figure 5 show the effects of the scenarios, including the risk factor of smoking. In 
Germany, the largest country, maintaining smoking at the high rates of younger cohorts would 
decrease the numbers of 65 and older, by the high mortality of smoking, and would decrease the 
numbers of disabled people disproportionately, as mortality among the disabled is even higher. If both 
able-bodied and disabled people quit (the NoSquit scenario), more disabled elderly people will survive 
to an older age. However, this is actually an effect of desirable life extension: quitting smoking is the 
single most important treatment in cardiovascular and respiratory diseases (among cancer patients, it is 
probably too late…). The difference between the SMOK and TREND scenario shows that quitting 
among smokers is the most important reason of disability increase: smokers with disease try to stop. If 
they do not, the prognosis is poor, mortality is high and disability will be compressed. But this is 
hardly advisable, common for all treatable diseases and would be a violation of the ‘rule of cure’. 
Indeed, the difference between accelerated quitting scenarios and the trend scenario is very small.  
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Table 7. The effect of changing smoking patterns on projected ADL disability in 2040 
65+ (X 1000)  Index 
Prev 
smoking  N n  disabl  Prev  65+ ADL 
DE 
2008 8.6  16519  3222  19.5%  100 100 
2040 
DELAY na 24307  5147  21.2%  147  160 
Trend 9.2  24187  5113  21.1%  146  159 
SMOK 22.1  23653  4916  20.8%  143  153 
noSMOK 1.2  24454  5067  20.7%  148 157 
NoSQuit 0.2  24687  5209  21.1%  149 162 
ES 
2008 7.7  7520 1794  23.9%  100 100 
2040 
DELAY na 14419  3161  21.9%  192  176 
Trend 8.6  14404  3161  21.9%  192  176 
SMOK 21.5  14139  3065  21.7%  188  171 
noSMOK 0.9  14534  3137  21.6%  193 175 
noSquit 0.2  14638  3200  21.9%  195  178 
NL 
2008 15.2  2415  403 16.7%  100  100 
2040 
DELAY na  4718  803  17.0%  195  199 
Trend 11.5  4729  805  17.0%  196  200 
SMOK 25.9  4617  766  16.6%  191  190 
noSMOK 1.7  4778 792  16.6%  198 197 
noSquit 0.3 4840  827  17.1%  200  205 
PL 
2008 11.1  5131 1852  36.1%  100  100 
2040 
DELAY na  8996  3548  39.4%  120  198 
TREND 10.6  9239  3591  38.9%  123 200 
SMOK 30.2  8830  3335  37.8%  117  186 
noSMOK 1.6  9374 3562  38.0%  125 199 
noSquit 0.2 9523  3681  38.7%  127  205 
  DEMOGRAPHIC EPIDEMIOLOGIC PROJECTIONS OF LTC NEEDS IN SELECTED EUROPEAN COUNTRIES | 17 
 
Figure 5. Change in basic ADL disabled elderly in 2040, compared to 2008, smoking scenarios 
 
Note: SMOK adds the numbers of disabled people when the prevalence of smoking remains constant at the 
values of the young cohorts in 2008. “Trend” is a realistic scenario assuming slowly declining prevalences 
(2% per year), and adds successful quitting at a rate of 2% per year. “Quit” is an accelerated quitting 
scenario, where no new inflowing cohorts are smoking and smokers quit at accelerated rates.  
 
6.  Strengths and weaknesses of the chosen approach 
The main strengths are the reliable population forecasts (regardless of unforeseen catastrophes), and 
the use of incidence rates to forecast the future prevalence of disability. We recalculated incidence 
from prevalence and mortality. However, this is not necessarily a weakness, as the transition from 
non-disabled to disabled occurs in a volatile and fluctuating chronic process. Indeed, incidence of 
chronic disease is often inconsistent with prevalence, as at the margins of that process, incidence and 
recovery occur frequently as a consequence of random fluctuations. In prospective studies, this allows 
for massive misclassification between disabled and non-disabled people, causing the inconsistency 
between incidence and prevalence. 
However, the data used are weak. Prevalence of basic ADL disability is highest among the oldest old 
population, but data on the prevalence of basic ADL disability in these populations are rare or absent. 
We are far more confident of the reliability of modelled trends than in the point estimates of basic 
ADL disability for 2008. Only very different age distributions make trends less certain. This might be 
a problem for Poland, but not for the other EU member states modelled. 
State and risk-factor-dependent mortality was taken from the Rotterdam study, starting in 1990, and 
applied to all populations (Hofman et al., 2006). Interactions with age were not significant and were 
ignored, but this might be caused by insufficient power to demonstrate interactions.  
We assumed equal mortality trends for disabled and non-disabled persons, or for persons with or 
without different risk status. This might not be true. Indeed, for dementia (a most important cause of 
disability), we can observe lower mortality at early stages but increased mortality at later clinical 
stages in more highly educated people, a consequence of more successful adaptation to cognitive 
decline by highly educated persons (Reuser, Willekens & Bonneux) They can stave off clinical 
dementia, until they reach advanced stages of severe disease and poor prognosis.  
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7.  Priorities for further research 
National estimates of ADL disability by age, gender and other characteristics, particularly at older 
ages are lacking. Within 20 years, the large birth cohorts of 1946 will celebrate their 85
th birthday in 
greater numbers than ever before. More than half of the men and two thirds of the women of the baby 
boom generation will survive their 85
th birthday according to prospective life tables (life tables that 
project the survival of cohorts), but we know very little about what is happening among the oldest old 
population; an age characterised by large variability in life histories. As there was a baby boom, we 
need a boom of research into the health of elderly people, particularly those of more advanced ages.  
Country-specific estimates of state and risk-factor-specific mortality will make country-specific 
forecasts more specific and reliable. SHARE can deliver this information in the future. However, the 
quality of mortality follow-up will have to be guaranteed. 
We assumed time trends in disability, based on existing data of time series of cross-sectional 
prevalences as mentioned in the international literature. With longer follow up, SHARE can inform us 
of trends in prevalence, and maybe even incidence. However, the same condition holds: the quality of 
follow-up will be of utmost importance. 
Conclusions 
The scenarios show the overriding influence of demographic change on future disability, with 
progressively smaller baby boom birth cohorts from the Netherlands, Spain, Poland, and Germany 
respectively. These forecasts are very robust: in the life table, 95% survive to age 55, when cohorts 
enter the model.  
Life extension is the second most important factor in the increase of disability. The simple linear 
forecasts of the EUROPOP scenarios project the period of unprecedented mortality decline among the 
55+ after the second world war to the future. The predicted life expectancy among women aged 65 in 
2040 is less than 24 years, which is still lower than the actual Japanese female life expectancy at age 
65 was in 2009 (24.0 years).   
Assuming that a constant disability incidence with sharply decreasing mortality would be a rather 
pessimistic (the chronology) scenario, the sharply decreasing disability, with little progress in 
cognitive causes of disability is rather optimistic (the biology scenario). However, the number of life 
years lived with a disability remained surprisingly constant in the Netherlands. The intermediary 
‘Delay’ scenario is therefore a somewhat conservative estimate.  
The effects of changing risk factors on disability prevalence are surprisingly small. First, there is 
demographic inertia: it takes many years to replace populations. Second, every person born between 
1943 and 1975 (or 1995) will add to the population of the elderly at risk of disability between 2008 
and 2040 (or 2060), but only a fraction of that population is at increased risk. A numerical example 
shows this. If one-sixth is disabled when not obese but one-third if obese, and 20 out of 100 persons 
are obese, then among these 100 persons, 20 persons will be disabled. The attributable risk then is one-
fifth minus one-sixth = 0.33, or in other words 3.3 added persons are disabled because of obesity. If 
the prevalence of obesity doubles, from 20% to 40%, the attributable risk doubles and the prevalence 
of disability increases from 20% to 23%. As in the Netherlands, if the population aged 65+ doubles 
from 100 to 200, there will be 46 disabled: 20 are added because of the doubling of the population, 6 
are added because of obesity. These are six too many, but still much more limited than the total 
demographic increase. 
The effects of quitting smoking are those of life extension. Smoking shortens life and shortens life 
with added disability. Indeed, many smokers improve the prognosis of their disease considerably by 
quitting. Extended survival by lifestyle modification can hardly be called a disadvantage. Even 
extreme scenarios would not add many disabled elderly people. Moreover, for every ‘bad’ year, two to 
three ‘good’ years are added, increasing the stock of competent elderly people, able to care for their 
other elderly citizens. DEMOGRAPHIC EPIDEMIOLOGIC PROJECTIONS OF LTC NEEDS IN SELECTED EUROPEAN COUNTRIES | 19 
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Appendices 
A1 Rationale 
In 2011, the large post-war baby boom, starting in 1946, reached the retirement age of 65. A ‘baby 
crash’ (a sharp decline in fertility) followed the baby boom, and is causing serious imbalances   
between the large baby boom generations and the small baby crash generations born after the 1970s.
3 
Extended life expectancy at old age is increasing the number of the oldest old (Oeppen & Vaupel, 
2002). Improving health care technology may extend life in disability; a striking example is the sharp 
decline in acute coronary heart disease mortality, creating large numbers of survivors with heart 
failure (Bonneux et al., 1994; Peeters et al., 2003). 
These developments are likely to cause imbalances between need and supply of long-term care (LTC), 
straining the financial sustainability of LTC systems. Since health and long-term care consumption by 
the elderly, especially by the very old and frail, is well above average, health care expenditures are 
likely to increase significantly (Meerding et al., 1998a; Meerding et al., 1998b). To address policy 
questions related to the provision of health care services in an ageing population, increasing emphasis 
has been put on the future development of long-term care need, supply and use, and the functioning of 
LTC systems. In this paper we use demographic models to project future needs of long-term care in 
the Netherlands, based on the EUROPOP 2008 mortality forecasts.
4 
Long-term care need is operationalised as having “at least one limitation in activities of daily living” 
(ADL-disability), based on the Katz ADL disability scale (Katz et al., 1963). ADL-disability is defined 
as self-reported difficulty with any of the following items: (a) bathing, (b) dressing, (c) eating, (d) 
indoor transferring and (e) toileting and continence. As generally the ADL items are rather 
hierarchical, a mean score on these items is a good indication of severity. 
Demand for care depends, among other things, on incidence, duration and severity of care dependence. 
A long-standing debate on compression or expansion of morbidity was started with the seminal paper 
of James Fries on compression of morbidity (Fries, 1980). Recent analyses confirm an extended life 
free of care and in good health (Manton, Gu & Lowrimore, 2008), but one which goes together with 
increased care-dependent life, as the incidence of care is strongly age-dependent (Olshansky, 1991). 
Fries posited morbidity as being independent of mortality: morbidity could be postponed, mortality 
was fixed by biology. At the other extremes, predictions of morbidity and health care costs that are 
age-dependent, posit the same independence, but now it is not mortality, but morbidity which is fixed 
(Bonneux et al. ,1998). Both disability and mortality at old age are strongly related processes, 
determined by increasing frailty, a consequence of ageing (Mitnitski et al., 2002). In recent periods, 
life expectancy is increasing by decreasing mortality of the elderly, being proportional in all age 
groups (Christensen et al., 2009; Vaupel, 2010). Changes in disability confirm a longer life in good 
health of the elderly (Cai & Lubitz, 2007; Manton, Gu & Lowrimore, 2008; Reuser, Bonneux & 
Willekens, 2010). Wear and tear is a chronological process, depending on the duration of exposure, 
and hence a chronological process, but repair and other plastic responses to damage by wear and tear 
are biological processes, which may be supported by healthy lifestyles and medical technology 
(Christensen et al., 2009). 
To assess dynamic changes in populations, we need information on dynamic change: transition rates 
(in demographic terminology) or incidences (in epidemiologic terminology). Through transitions, 
people move from the one state to the other or to death; the end state.  
In a cohort model, numbers of people start in a certain state, and move through states until death. In 
multi-state life tables, this translates as time spent in a certain state, adding up to a life expectancy at a 
certain age in certain states. In a simple three-state model (alive without disease, alive with disease, 
                                                      
3 See http://europa.eu/legislation_summaries/employment_and_social_policy/situation_in_europe/c10160en.htm,  
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death), a cohort model shows life expectancy with or without disease. In a population model, people 
enter the model during a certain period at a certain age, and move through age and time until they die. 
In each age/time unit, they can transit to disability or to death. In each period, numbers of survivors in 
each state at each age are determined by current and past transition rates. If we describe life tables, we 
describe the period life table: the life table resulting from the age-specific transition rates in a specified 
(smaller) period. Of course, once the future transition rates are defined, cohort life tables can be 
described. This would be the life history of individual people entering the model at a certain age, 
followed up through future time till death. A period life table in 2060 of, say, people aged 65, is 
defined by the transition rates in the population of 65 and older in 2060, and 2060 only. A cohort life 
table would be people entering at age 65 in a certain year, say 2010, and then followed up till 2045 
(when the life tables are closed at age 100). This cohort life table would summarise the experience of a 
cohort of 65 year-olds over an extended period of 35 years. In a simple three-state model, we need to 
identify four incidence flows at every age: incidence (from healthy to disabled (or infirmity, to avoid 
the D from death, H2I), recovery (from infirmity to health, I2D), death in the state healthy (H2D) or in 
the state infirmity (I2D). The limitation in the number of states is less inspired by the technological 
possibilities than by the possibilities of estimation. 
If we add risk factors, we can make these transitions risk-factor-dependent. Obesity increases the risk 
of disability, often just by putting more weight on joints. Smoking is a dangerous fatal habit that 
increases the risk of dying: all things being equal, smoking therefore tends to decrease disability and 
associated care needs in a population. In the simplest setting possible, we define two risk states in two 
risk factors (obese or not, or smoking or not). Obese is defined as having a BMI of 30 and more. 
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Table A.1 Summarising source of data and assumptions 
All data are specified by country, sex and single year of age, unless stated otherwise. Projections 
are made between the years 2008 and 2060. Results are presented as for 2040 (when the large baby 
boom birth cohorts of 1945-1965 are 75-95 year old, and the peak of ageing is reached). 
A Assessment in start year 2008. 
A1 Population of 2008 (Eurostat) 
A2 Mortality in 2008 (Eurostat) 
A3 Prevalence of risk factors, basic ADL disability and risk factor specific disability. Source: 
EUROSTAT (population), SHARE (European survey, community dwelling elderly), ANCIEN 
(basic ADL disabled elderly in institutions).  
A4 Risk and disability specific mortality ratios (Rotterdam Study, prospective study). 
B Forecasts of population and mortality 
B1 Entry at age 55 between 2009 and 2060 as projected by EUROPOP 2008 
B2 Mortality between 2009 and 2060 as projected by EUROPOP 2008 
C Scenarios of disability without risk factors 
C1 In the CONST scenario, mortality between 2008 and 2060 is kept constant. 
C2 PREV: constant age-specific prevalence of disability 
C3 CHRON: constant age-specific incidence of disability 
C4 BIOL: relative disability incidence decline similar to mortality. Yields high incidence declines 
at young age, but lower at older ages. 
C5 DELAY: disability incidence delayed with the same time, similar to mortality. Yields higher 
disability incidence at older ages, but smaller incidence at younger age. 
D and E Scenarios of risk factors 
D1 BMI: Delay scenario with future inflow of obese people at age 55 at current prevalence. 
D2 FAT: Delay scenario with future inflow obese people at age 55 at double the prevalence of 
2008 in 2060. 
D3 LEAN: Delay scenario with future inflow of obese persons at age 55 at half the prevalence of 
2008 in 2060. 
E1 SMOK. The (high) smoking prevalence at younger ages are kept constant and propagated in the 
future. Smokers die at an increased rate, decrementing smoking prevalence.  
E2 TREND. The (high) smoking prevalence at younger ages are propagated in the future, but 
smokers quit successfully at a rate of 2% per year.  
E3 NOSMOK. All people quit before age 55. 100% no smokers flow in at age 55 – but it will take 
45 years for the remaining smokers to die. 
E4 NoSquit. All people quit before age 55, but the remaining smokers quit at an increased rate of 
4% per year.  DEMOGRAPHIC EPIDEMIOLOGIC PROJECTIONS OF LTC NEEDS IN SELECTED EUROPEAN COUNTRIES | 23 
 
Table A.2 Prevalence of disability by country and five year groups (source: SHARE 2004-2006 and LTC data 2008)  
Population  In community  In LTC 
% disab 
commun  % in LTC  As observed  As modelled  % as obs  % as exp 
DE 
M 65-69    2,552,272  2,533,932 18,340 7.0% 1 195,847.6 172,625 7.7% 6.8% 
70-74   1,933,383  1,910,831 22,552 9.1% 1 197,764.8 227,356 10.2% 11.8% 
75-79   1,281,058  1,253,983 27,075 17.0% 1 245,127.4 254,020 19.1% 19.8% 
80-84   730,162  700,376 29,786 28.7% 1 239,513.4 221,513 32.8% 30.3% 
85+ 448,078  403,075 45,003 48.0% 1 260,080.4 234,570 58.0% 52.4% 
F 65-69    2,771,752  2,755,023 16,729 8.5% 1 2,512,610.9 270,669 9.1% 9.8% 
70-74   2,285,279  2,255,554 29,725 13.7% 1 342,369 349,782 15.0% 15.3% 
75-79   1,767,864  1,710,120 57,744 16.9% 1 357,258.1 408,866 20.2% 23.1% 
80-84   1,461,945  1,343,766 118,179 26.1% 1 499,556 471,528 34.2% 32.3% 
85+ 1,286,950  992,318 294,632 54.9% 1 1,000,885 611,171 77.8% 47.5% 
All 16,518,743  15,858,978 659,765 2,684,031 659,765 3,589,664 3,222,100 21.7% 19.5% 
Fraction Institutionalised (75+)  9.5%
Fraction disabled in institute (75+)  18.4%
ES 
M 65-69    894,485  69,755 69,755 75,074 8.4% 
70-74   847,599  91,337 91,337 111,875 13.2% 
75-79   706,811  26,541 113,017 1 139,558 139,018 19.7% 
80-84   450,739  38,144 113,795 1 132,867 128,805 28.6% 
85+ 290,548  133,705 152,777 131,288 45.2% 
F 65-69    1,003,665  112,145 112,145 109,375 10.9% 
70-74   1,030,886  157,029 157,029 188,820 18.3% 
75-79   954,907  32,987 211,187 1 244,174 264,552 27.7% 
80-84   714,212  124,849 239,528 1 289,478 280,309 39.2% 
85+ 626,456  359,162 434,060 364,476 58.2% 
All 7,520,308  222,521 1,553,297 1,775,818 1,553,297 23.6% 20.7% 24 | BONNEUX, VAN DER GAAG & BIJWAART 
 
Fraction Institutionalised (75+)  5.9% 0.206547
Disabled in institute (75+)  12.5%
NL 
M 65-69    356,076  353,008 3,068 4.9% 65.8% 19,333 14,040 5.4% 3.9% 
70-74   274,516  269,011 5,505 5.2% 58.8% 17,295 21,510 6.3% 7.8% 
75-79   206,574  196,892 9,682 8.3% 64.3% 22,486 28,680 10.9% 13.9% 
80-84   125,720  112,531 13,189 14.3% 70.7% 25,404 28,187 20.2% 22.4% 
85+ 76,075  54,815 21,260 40.0% 79.1% 38,751 28,009 50.9% 36.8% 
F 65-69    369,382  365,892 3,490 5.4% 62.9% 21,865 21,638 5.9% 5.9% 
70-74   314,516  306,495 8,021 8.7% 64.1% 31,709 36,942 10.1% 11.7% 
75-79   278,271  259,095 19,176 14.6% 73.8% 52,038 56,734 18.7% 20.4% 
80-84   216,243  181,660 34,583 23.4% 85.9% 72,274 68,387 33.4% 31.6% 
85+ 197,454  116,204 81,250 40.4% 93.4% 122,809 98,560 62.2% 49.9% 
All 2,414,827  2,215,604 199,223 259,288 164,676 423,963 402,687 17.6% 16.7% 
Fraction Institutionalised (75+)  18.1% 10.7%
Disabled in institute (75+)  47.0%
PL 
M 65-69    623,780  0.2039474 127,218 118,565 20.4% 19.0% 
70-74   552,652  0.1969697 108,856 135,283 19.7% 24.5% 
75-79   425,276  0.3883495 165,156 142,939 38.8% 33.6% 
80-84   224,505  0.3703704 83,150 105,527 37.0% 47.0% 
85+ 110,084  0.6153846 67,744 74,301 61.5% 67.5% 
F 65-69    829,973  0.3 248,992 207,732 30.0% 25.0% 
70-74   825,005  0.3142857 259,287 265,723 31.4% 32.2% 
75-79   734,451  0.4100719 301,178 310,166 41.0% 42.2% 
80-84   502,783  0.5352113 269,095 274,753 53.5% 54.6% 
85+ 302,867  0.6571429 199,027 216,857 65.7% 71.6% 
All 5,131,376  1,829,703 1,829,703 1,851,846 35.7% 36.1% 
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A2 Short description of the statistical analysis of the SHARE and Rotterdam 
Study 
We extracted the data for DE, ES, NL and PL from the SHARE database (Waves 1 and 2, except for 
Poland that only participated in round 2). basic ADL were identified by the KATZ variables identified 
in module PH049 (version 2004). These include having difficulties expected to last at least three 
months in 1) Dressing, 2) Walking across a room, 3) Bathing or showering, 4) Eating, such as cutting 
up your food, 5) Getting in or out of bed, 6) Using the toilet, including getting up or down. For 
comparability with the Katz scale, 2 and 5 are combined into one variable, and considered positive if 
at least one was positive. The distributions of the five concerned basic ADL were defined per 
individual record and by country. Response rate was (to be added for each country). 
Obesity was identified according to international convention as a BMI (weight over length squared, 
identified by self-reported answers on questions PH012 and 013) of 30 or more. To avoid confounding 
by reverse causation and high mortality of diseased persons with severe weight loss, we excluded 
those persons with a BMI of less than (to be added). Excluded were: (% DE, ES, NL, PL). Smoking 
was identified as being a current smoker (BR002). 
The results are presented in Table A2. 
Follow-up data were kindly provided by the Rotterdam Study. The Rotterdam Study is a large 
prospective study on ageing in a Dutch community. (‘Erasmus Rotterdam Gezondheid Onderzoek’ 
ERGO’ (Hu et al., 2005). The study started in 1989, the first round of which covered the period 1989-
1993. In total, 7,983 persons took part in the survey. The fifth wave is now coming to an end and the 
results were scheduled to be available by 2011. In the fourth wave of the original group of 
respondents, 3,550 were left. After the third wave a group of 3,011 new respondents were added to the 
survey population. After the fourth wave another group of 4,000 young persons was added. Among 
others, the survey includes questions on mortality (all waves, complete data available) and morbidity 
(HAQ and IDAL, Lawton; not included in wave 2). The Health Assessment Questionnaire (HAQ) and 
Instrumental Activities of Daily Living-scale measure disability slightly different from Katz-ADL 
disability. 
The relative mortality risks are calculated using Cox models. We identified proportional hazard ratios 
of all cause mortality, defined by disability status and risk factor status. Interactions with age were not 
statistically significant and therefore ignored. These generic PHR were applied to country-specific 
mortality and prevalence to identify country specific mortality by disability and risk factor status. The 
central assumption is that the relative risks between risk factors and disability status are comparable in 
European populations, but not the absolute risks.  
To note the high mortality of smokers, and the relative protection of obesity when disabled (known in 
the medical literature as the “obesity paradox”: obesity increases the risks of disease, but decreases the 
risk of death when diseased). 
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Table A.3 Results of analysis 
Proportional hazard ratios.  M  F 
Non-disabled, non-smoking  1 (ref) 1 (ref)
disabled, non-smoking  1,89 1,55
Non-disabled, smoking  1,70 1,80
disabled, smoking  3,21 2,79
Non-disabled, non-obese  1 (ref) 1 (ref)
disabled, non-obese  1,89 1,55
Non-disabled, obese  1,11 1,11
disabled, obese  1,72 1,41
 
Proportional hazard ratios for all causes of death, compared to a reference populations which is not 
disabled and not exposed. 
 
 
A3 Description of the incidence-prevalence model 
See below, from page 30 onwards. 
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A4 Description of the multistate demographic model and demographic input 
To project the number of care-dependent elderly people we used a general projection framework 
distinguishing different groups of persons by ADL disability and risk factor(s). As a point of departure 
we used the set of internationally consistent population scenarios for the countries of the European 
Union (EU), Norway and Switzerland compiled by Eurostat (EUROPOP 2008).
5 This set of scenarios 
has been developed in a consistent framework of convergence. It describes the possible future 
demographic developments assuming that in the long run (2150) fertility and mortality across 
countries converge to the ‘forerunners’ or best performers within the EU. Concerning international 
migration, it is assumed that migration flows will converge eventually to zero net migration. 
Whenever the projections resulted in a shortage of the working age population, however, migration 
has been adjusted upwards. To attune our scenarios as much as possible to the EUROPOP 2008 
scenarios, we start our projections at age 55 and base the population inflow at age 55 for all years in 
the projection period on the outcomes of the EUROPOP 2008 scenarios. As a result, migration is 
largely covered by EUROPOP 2008 and the population at age 55 is exactly the same as the 
EUROPOP 2008 scenario. From age 55 onwards our projections will start to deviate to a greater or 
lesser extent from EUROPOP 2008, depending on the assumptions of the scenarios. Migration at ages 
55 and over has been ignored.  
As we lack reliable and comparable data on trends of ADL disability, we based our disability forecasts 
on the mortality forecasts of the EUROPOP 2008 scenarios. These mortality forecasts co-determine 
our disability projections, which are therefore entirely consistent with the EUROPOP 2008 scenarios.  
In a dynamic multi-state projection life table model, the distribution of people in states is the outcome 
of transitions people make during their life course. The rates of transition determine cohort and 
population dynamics. We used the multi-state projection model LIPRO (available at the NIDI website) 
that generates cohort biographies by conventional macrosimulation. The set of possible states in a 
projection framework is the state space. For our base projections of ADL disability we used a 
simplified general state space (the set of possible states in a projection model) of three states:
6 
1.  non-Disabled (nD) 
2.  Disabled (D) 
3.  the absorbing end state: death 
The states determine the possible transitions. Persons can become disabled, can recover from disability 
or can die. The transitions between the states are represented in Figure A1.  
Figure A.1State space ADL-disability model 
 
 
                                                      
5 See: http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-SF-10-001/EN/KS-SF-10-001-EN.PDF.  
6 At a later stage we will add the risk factors of smoking and body mass index to the model. 
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The arrow i refers to disability incidence rates and r to recovery from disability rates. Persons, either 
non-disabled or disabled, can enter the population at age 55 (arrows p1(55) and p2(55)) or can leave 
the population by dying (arrows d1 and d2).  
Due to the lack of reliable data on incidence of disability, we used prevalence data to estimate the 
incidence rates. Prevalence of disability at a certain age and a given point in time is the outcome of 
previous developments in incidence of recovery. As a consequence, by using prevalence data to 
estimate incidence, the resulting incidence into disability refers in fact to a ‘net number’ of disabled 
persons. In theory, countless combinations of incidence and recovery can result in the same prevalence 
figures. For our model, therefore, we set recovery at zero (r=0) as it is already covered by the (net) 
incidence rates.  
Using SHARE survey data
7 we estimate the prevalence in the states nonDisabled and Disabled by age 
and sex (p1(x) and p2(x)). Knowing the prevalence of each state at age x together with the age-specific 
incidence rates i1(x) and mortality rates for non-disabled and disabled persons (d1(x)and d2(x)), we 
can calculate the prevalence in the states nonDisabled and Disabled at age x+1 (p1(x+1) and p2(x+1)). 
The prevalence of disability at age x+1 for instance can be calculated as all persons in the state 
Disabled at age x+1 divided by all persons survived until age x+1. The persons in the state Disabled at 
age x+1 are determined as all persons in that state at age x that do not leave the state to go to another 
state or due to death, plus all persons that enter the state. Thus, if we know the incidence rates i(x), the 
mortality rates d1(x) and d2(x) and the prevalence at age 55 p1(55) and p2(55), we can calculate the 
prevalence of disability for all ages above age 55. However, we do not know the incidence rates, but 
conversely will estimate them using the prevalence. For this we use the following iterative procedure: 
From EUROPOP 2008 we know the mortality rates by age and sex for the total population (dtot(x)). 
As total mortality is the sum of mortality in the two states nonDisabled and Disabled, and mortality 
rates of disabled persons d2(x) can be defined relatively to mortality rates of non disabled persons 
d1(x), we can calculate d1(x) using dtot(x) and the relative risk RR for the state Disabled (state 2) 
relative to the state nonDisabled. Assuming a linear model, this comes down to the following:  
dtot(x) = p1(x) d1(x) + p2(x) d2(x)   (1) 
which can be rewritten as 
dtot(x) = p1(x) d1(x) + p2(x) RR d1(x) or 
dtot(x) = (p1(x) + p2(x) RR) d1(x) or 
d1(x) = dtot(x) / (p1(x) + p2(x)RR)   (2) 
Once we have calculated d1(x) we can easily calculate d2(x) by multiplying d1(x) with relative risk 
RR.  
Next we use the age, sex and disability specific mortality rates together with the estimated prevalence 
to estimate the age and sex specific incidence rates i(x) applying the following two optimization 
criteria:  
1.  The total number of deaths as a sum of the number of deaths of non-disabled and disabled persons 
should be equal to the number of deaths based on EUROPOP 2008, and  
2.  The squared differences between the estimated prevalence in the states nonDisabled and Disabled 
(the prevalence input) and the calculated prevalence based on the estimated incidence and 
mortality rates (the prevalence output) should be minimised.  
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As long as the prevalence input differs from the prevalence output, in a next step the prevalence output 
will be used as input to re-estimate the disability-specific mortality rates and subsequently the 
incidence rates. This procedure will be repeated until convergence.  
The linear estimation procedure provides only reliable estimations of the rates in case the age patterns 
follow a linear curve. For mortality and incidence rates, however, the exponential function fits the age 
pattern much better than the linear function, especially at higher ages. Therefore, we used the 
exponential approach to estimate the incidence and mortality rates. Although the exponential approach 
is mathematically more complicated than the linear approach, the reasoning behind both approaches is 
similar. A detailed description of the exponential approach for the estimation of incidence and 
mortality rates (including risk factors) is given in A3.   
In order to give an indication of the severity of disability we calculate the average ADL-score using 
the age-specific distribution of ADL disability across the different ADL-scores obtained from SHARE 
(from one to five limitations).  Estimation of Disability Incidence based on Prevalence
Govert E. Bijwaard
April 20, 2011
1 Estimation of Incidence and mortality
We assume that the observed prevalences are the result of a stationary Markov process and
that disability is irreversible. In a Markov process a one-to-one relation between the transition
rates and the transition probability, the probability to change from one state to another in a
given time/age period (usually one year), exits. A Markov model is usually deﬁned in terms of
the transition rates between the possible states. The changes in prevalence are directly related
to the transition probabilities. The estimation procedure is based on this relation.
1.1 Two states model: Illness-death model
For each age x (and gender) we have the following matrix of transition rates (between the two
states {nD, D } and the death-state):
M(x) =


 

−
 
θ(x) + µnD(x)
 
θ(x) µnD(x)
0 −µD(x) µD(x)
0 0 0


 

where θ(x) is the disability incidence rate at age x, (µnD(x),µD)(x) are the mortality rates at
age x for the non-disabled and disabled state. Note that θ(x) is the “net-incidence”. It is not
possible to estimate both incidence and recovery when only the prevalences in the two states
and the total death rate is available.
Let QD(x) be the disability prevalence at age x (by gender) and QnD(x) be the complement,
the prevalence of non-disability at age x. Let Pij(x) be the age-speciﬁc transition probability
from i = {nD,D} to j = {nD,D,death} from age x to age x + 1 (conditional on survival up
to age x), that is, the probability
1QD(x + 1) =
 
QnD(x)PnD,D(x) + QD(x)PD,D(x)
 
/S(x) (1)
QnD(x + 1) =
 
QnD(x)PnD,nD(x) + QD(x)PD,nD(x)
 
/S(x) (2)
with S(x) is the survival of all individuals, disabled and non-disabled, from age x to x+1, i.e.,
S(x) = QnD(x)
 
PnD,nD + PnD,D(x)
 
+ QD(x)
 
PD,nD(x) + PD,D
 
(3)
Division by the survival rate is needed because the prevalence at the next age is based on the
survivors up to that age.
The transition probability (matrix) follows from the (matrix of) transition rates:
P(x,x + 1) = exp(M) = V ΛV
−1 (4)
where V is the matrix of eigenvectors of M and Λ is the exponentiated matrix of eigenvalues,
i.e. if the eigenvalues of M are λ1,λ2,λ3 then Λ = diag
 
eλ1,eλ2,1
 
with λ3 = 0. In the 2-state
illness-death model (without recovery) the transition probability has an analytical solution (see
for example Singer and Spilerman (1976))
PnD,nD(x) = e
−
 
θ(x)+µnD(x)
 
(5)
PnD,D(x) =
θ(x)
µD(x) − θ(x) − µnD(x)
 
e
−
 
θ(x)+µnD(x)
 
− e
−µD(x)
 
(6)
PD,nD(x) = 0 (7)
PD,D(x) = e
−µD(x) (8)
For known prevalence, total (age-gender speciﬁc) mortality, µtot(x) and relative mortality
risk µD(x) = rD·µnD(x) we can solve for the age-speciﬁc incidence and (non-disabled) mortality
rate through the following iterative procedure
1. Calculate start value for µnD(x) by solving:
exp
 
−µtot(x)
 
= QnD(x)exp
 
−µnD(x)
 
+ QD(x)exp
 
−rD · µnD(x)
 
2. Given µnD(x) and observed QnD(x + 1) solve equation 2 for θ(x)
argθ
 
Q
θ
nD(x + 1) = QnD(x + 1)
 
3. Given θ(x) solve for µnD(x) using:
exp
 
−µtot(x)
 
= QnD(x)
 
1 − PnD,nD(x) − PnD,D(x)
 
+ QD(x)
 
1 − PD,D(x)
 
4. Repeat step 2 and 3 till convergence
21.2 Group speciﬁc incidence rate
It is very likely that the disability-incidence depends on observed characteristics, like, e.g.,
smoking status, obesity or education level. If no transitions between the groups exit, the method
in the previous section can easily extended to estimate the incidence rates by using group-
speciﬁc transition matrices. However, because this resulted in unrealistic results. We therefore
take a slightly diﬀerent route, that uses the results from the illness-death model as input.
Now we assume that the disability incidence and the mortality estimated before is a weighted
average of the incidence and mortality by group (smoking- or obesity-status). For exam-
ple, for smoking we know the age-speciﬁc prevalence, {QnSnD(x),QnSD(x),QSnD(x),QSD(x)},
the age-speciﬁc disability (ADL-only), θ(x), the age-speciﬁc mortality by disability status,
{µnD(x),µD(x)}. To estimate the smoking-speciﬁc incidence and mortality rates we need the
relative mortality risk of smoking, rS (assumed independent of age) and the relative incidence
risk of smoking, iS (also assumed independent of age), see Table 1.
Then, the mortality of a non-smoking disabled individual at age x, µnSD(x) solves:
e
−µD(x) =
QSD(x)
QSD(x) + QnSD(x)
e
−rS·µnSD(x) +
QnSD(x)
QSD(x) + QnSD(x)
e
−µnSD(x) (9)
and mortality of smoking individual at age x is rS · µnSD(x). The mortality of a non-smoking
non-disabled individual at age x, µnSnD(x) solves
e
−µnD(x) =
QSnD(x)
QSnD(x) + QnSnD(x)
e
−rS·µnSnD(x) +
QnSnD(x)
QSnD(x) + QnSnD(x)
e
−µnSnD(x) (10)
and mortality of smoking non-disabled individual at age x is rS · µnSnD(x). For incidence by
smoking status we have a similar equation to solve. The disability incidence of a non-smoking
individual at age x, θnS(x), solves
e
−θ(x) =
 
QSD(x) + QSnD(x)
 
e
−iS·θnS(x) +
 
QnSD(x) + QnSnD(x)
 
e
−θnS(x) (11)
and the disability incidence of a smoking individual at age x is iS · θnS(x).
Of course, the model for obesity is similar, only the prevalences and the relative risks change.
3Table 1: Estimated relative risks
Mortality risk disability (only)a
non-disabled disabled
Males 1 1.89
Females 1 1.55
Mortality risk smokinga , rS
non-smoking smoking
Males 1 1.70
Females 1 1.80
Disability incidence risk smokingb , iS
Males 1 1.15
Females 1 1.05
Mortality risk obesityb , rO
non-obese obesec
Males 1 1.11
Females 1 1.11
Disability incidence risk obesityb , iO
Males 1 1.715
Females 1 1.715
a Source ERGO.
b Source Walter et al. (2009).
c Obese is deﬁned as BMI > 30.
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